Maintenance Therapy With Interleukin-2 for Childhood AML-Reference-Cited by-同舟云学术

Maintenance Therapy With Interleukin-2 for Childhood AML

Published:2018-12 Issue:6 Volume:2 Page:e159
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Petit Arnaud,Ducassou Stéphane,Leblanc Thierry,Pasquet Marlène,Rousseau Alexandra,Ragu Christine,Cachanado Marine,Nelken Brigitte,Bertrand Yves,Michel Gérard,Gandemer Virginie,Cuccuini Wendy,Fenneteau Odile,Lapillonne Hélène,Auvrignon Anne,Baruchel André,Leverger Guy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference51 articles.

1. Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990–1999;Clavel;Eur J Cancer Prev.,2004

2. Results of a randomized trial in children with acute myeloid leukaemia: medical research council AML12 trial;Gibson;Br J Haematol.,2011

3. Randomized trial comparing liposomal daunorubicin with Idarubicin as induction for pediatric acute myeloid leukemia: results from study AML-BFM 2004;Creutzig;Blood.,2013

4. Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531;Gamis;J Clin Oncol.,2014

5. Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit—multicenter studies of the French LAME (Leucemie Aigue Myeloblastique Enfant) Cooperative Group;Perel;Leukemia.,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia;Blood Advances;2024-06-14

2. Immune Microenvironment in Childhood Cancers: Characteristics and Therapeutic Challenges;Cancers;2024-06-12

3. Orientation et prise en charge de la leucémie aiguë myéloïde néonatale : recommandations du comité leucémies de la SFCE;Bulletin du Cancer;2024-05

4. Natural Killer Cell Cellular–Based Therapeutic Options for Management of Acute Myeloid Leukemia: Prospect and Challenges;2023-11-06

5. Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia;Cancers;2023-08-18